Banner
HomeLast Word → How to incentivize higher quality and lower cost in U.S. medical care

How to incentivize higher quality and lower cost in U.S. medical care Print E-mail
Written by Samuel Falkson | KevinMD   
Thursday, 01 March 2018 00:00

U.S. health care costs are high - over $3 trillion annually and about 18 percent of our GDP. Estimates suggest that our costs are rising. Concomitantly, we are entering an era of extreme biomedical promise, where research breakthroughs are translating into unprecedented clinical benefit. Luxturna from Spark Therapeutics, for example, remarkably restores vision loss in patients with a specific eye disease. With amazing innovations, however, come high price tags. At $850,000 per treatment, Luxturna carries the highest price for any medication in U.S. history. The introduction of expensive miracle treatments raises questions about how to pay for such therapies. Our health care system is already financially burdened, yet it seems unfathomable to restrict a sick person's access to breakthrough cures for fiscal reasons. How do we create a health care system that keeps pace with technological innovations?

Last Updated on Friday, 02 March 2018 16:38
 


Banner
Website design, development, and hosting provided by
Netphiles